The nation of Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's request for confidential information.
This rejection was revealed following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesman later stated that the United States was demanding access to health data for research and commercial gain but refused to guarantee the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to reach a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a related health funding agreement after legal challenges were raised about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to boost transparency and responsibility.
According to statements, Sixteen nations in Africa have so far signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.
"In essence, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be available to our people if a future health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures previously established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage future pandemics.
"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome continued discussions with our US partners on how future collaboration could be designed in a manner that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body stated it recognised the government's concerns, but urged that talks should continue given that a large portion of the country's Aids initiatives depended on foreign aid.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it added.
The situation highlights the ongoing debate between accepting vital international aid and protecting local interests in an ever more data-driven world.